List of works - Timothy Beukelman

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

scientific article published on April 2011

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

scientific article

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis [...]

scientific article

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis

scientific article published on 25 April 2019

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

scientific article published on 25 April 2019

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

scientific article published on 15 February 2016

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities

scientific article

Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients

scientific article published on 05 September 2016

Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster

scientific article published on March 2013

Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease

scientific article

Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance

scientific article

Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility

scientific article

Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis.

scientific article published on 15 September 2006

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis

scientific article published on May 2013

Consensus treatment plans for new‐onset systemic juvenile idiopathic arthritis ⬇️

scientific article published on July 1, 2012

Development and retrospective validation of the juvenile spondyloarthritis disease activity index

scientific article

Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry

scientific article published on August 2012

Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry

scientific article

Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).

scientific article

Geographic distribution of endemic fungal infections among older persons, United States

scientific article published in September 2011

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

scientific article published on 16 August 2010

High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. ⬇️

scientific article published on 9 August 2011

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients

scientific article published on May 2015

Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States

scientific article published on 5 July 2012

Infectious Complications in Juvenile Idiopathic Arthritis ⬇️

scientific article published on May 1, 2013

Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study

scientific article

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

scientific article

Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis

scientific article

Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches

scientific article

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study

scientific article

Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis

scientific article

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans

scientific article published on 11 April 2017

Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.

scientific article

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

scientific article

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

scientific article published on 10 February 2012

Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report.

scientific article published on 04 June 2013

Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis

scientific article published on 15 May 2012

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

scientific article published on 7 March 2014

Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura.

scientific article published on July 2009

Sarcoidosis in a young child with Alagille syndrome: a case report

scientific article published on 31 August 2012

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

scientific article

The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents

scientific article

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months

scientific article

The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.

scientific article published on 22 September 2016

Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases

scientific article published on January 2013

Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome

scientific article

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

scientific article published on October 2012

Using registries to identify adverse events in rheumatic diseases.

scientific article published on 21 October 2013

What is the background incidence of malignancy in children with rheumatic disease?

scientific article published on March 2013

List of works by Timothy Beukelman

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis [...]

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities

Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients

Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster

Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease

Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance

Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility

Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis.

Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis

Consensus treatment plans for new‐onset systemic juvenile idiopathic arthritis ⬇️

Development and retrospective validation of the juvenile spondyloarthritis disease activity index

Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry

Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry

Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).

Geographic distribution of endemic fungal infections among older persons, United States

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. ⬇️

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients

Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States

Infectious Complications in Juvenile Idiopathic Arthritis ⬇️

Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases

Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis

Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches

Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study

Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans

Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report.

Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura.

Sarcoidosis in a young child with Alagille syndrome: a case report

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months

The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.

Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases

Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome

Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

Using registries to identify adverse events in rheumatic diseases.

What is the background incidence of malignancy in children with rheumatic disease?